Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Interventional Cardiology Devices Market

  • MAR2979430
  • 219 Pages
  • March 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Global Interventional Cardiology Devices Market was valued at US$ xx Mn in 2016 and is expected to reach US$ xx Mn by 2022 growing at a CAGR of xx% during the forecast period. Interventional cardiology devices are used to treat heart disease, and most of the heart diseases have some serious medical conditions, such as angina, congestive heart failure, and arrhythmias. These are often caused by partially blocked coronary arteries, which is the most common cause of death globally. Blocked coronary artery clogs the supply of blood to the heart. The coronary artery can be narrowed or blocked due to the formation of plaque, which forms due to reasons such as cholesterol, fatty deposits, calcium, etc. Interventional cardiology devices are used to treat such conditions. The devices used in interventional procedures include catheters, stents, intravascular imaging systems, and guide wires to treat cardiac disorders.

Market Dynamics

The rapidly growing incidences of cardiac disorders along with demand for minimally invasive treatment due to less complication, changing lifestyle and rise in older population are the prime drivers for the interventional cardiology devices market. Moreover, increasing awareness among the patient population in developing countries along with favorable government initiatives and technical advancements has led to the increased importance of this market.

The high cost of the devices, many entry barriers, and stringent government policies put constraints on the market.

Market Segmentation

The market is segmented by type of products (Catheters, Balloons (Scoring balloons, Cutting balloons and Drug Eluting balloons), Stents (Bare Metal stents, Drug Eluting Stents and Bioresorbable Stents), Guidewires, Vascular Closure Devices and Atherectomy Devices), by end users (ASCs, Hospitals, Physicians' office) and by region (North America, Europe, Asia-Pacific and the Rest of the World).

Geographic Analysis

North America leads the interventional cardiology devices market followed by Europe. Moreover, Asia-Pacific region is expected to grow rapidly due to rising population and technological development.

Key Players

Some of the major players in the market include Abbott Vascular, Boston Scientific, Cordis, Medtronic, St. Jude Medical and Lombard Medical Inc.

The report contains comprehensive analysis on:

--> Interventional Cardiology Devices Market Segments

--> Interventional Cardiology Devices Market Drivers, Restraints and Opportunities

--> Interventional Cardiology Devices Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Interventional Cardiology Devices Market Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Interventional Cardiology Devices Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390